HomeSearch

UncategorizedHow AI Advancements are Improving Cancer and Mesothelioma Research

June 13, 20230
How can AI be used to further mesothelioma research? Article written by Miranda Sudo   Modern advancements in artificial intelligence, commonly referred to as AI, have been greatly impacting many industries including scientific research. Recently, one of the leading European companies for AI-powered drug discovery and clinical development, AI Biotech Owkin, received a letter of...

UncategorizedMesothelioma Treated with Pre-Operative Immunotherapy Exhibits Promising Results

April 17, 20230
Article by Miranda Sudo A new study conducted by Baylor College of Medicine showed promising results using preoperative immunotherapy to treat patients with resectable malignant pleural mesothelioma. Immunotherapy drugs, which work by helping a patient’s immune system recognize cancer cells and strengthening its response to destroy them, have recently been showing positive results in treating...

UncategorizedBAP1 Mutation Study at University of Hawaii Cancer Center

March 6, 20230
  Mesothelioma specialists Haining Yang and colleagues of the University of Hawaii Cancer Center have focused years of their studies on increasing the survival rate of mesothelioma. Recently, they obtained a $2.6 million grant from the NIH to fund their research on BAP1 genetic mutation and predisposition to mesothelioma. Mesothelioma is a cancer of the...

UncategorizedNon-Small Cell Lung Cancer Radiotherapy Clinical Trial at VA

February 2, 20230
Summary: Patients with stage I non-small cell lung cancer have been historically treated with surgery whenever they are fit for an operation. However, an alternative treatment known as stereotactic radiotherapy now appears to offer an equally effective alternative. Doctors believe both are good treatments and are therefore conducting this study to determine if one may...

UncategorizedPegasys: A potential new treatment for mesothelioma

December 2, 20220
Recently, researchers have been investigating the use of peginterferon as a treatment for mesothelioma cancer. Article by Miranda Sudo   Pegasys, also known generically as peginterferon, is a prescription antiviral drug currently used to treat Hepatitis B and C. It’s a type of immunotherapy that combines interferon, a human protein produced by the body to...

UncategorizedImmunotherapy as a Treatment for Mesothelioma

October 10, 20220
Article by Miranda Sudo What is Immunotherapy? Immunotherapy uses parts of a person’s immune system to fight diseases, including certain cancers. Normally, when new substances like a bacteria or virus enter your body, your immune system recognizes them as “foreign”. It then attacks the “foreign” cells and destroys them. However, with cancer your immune system...